Johnson & Johnson Ordered To Pay $572.1M For Oklahoma Opioid Abatement Program
NORMAN, Okla. — An Oklahoma state court judge on Aug. 26 ordered Johnson & Johnson and subsidiary Janssen Pharmaceuticals Inc. to pay $572.1 million to fund the first year of the...To view the full article, register now.
Already a subscriber? Click here to view full article